Cue Biopharma (CUE) Asset Utilization Ratio (2018 - 2026)

Cue Biopharma has disclosed Asset Utilization Ratio across 9 years of filings, most recently posting 0.62 for Q2 2026.

• In Q2 2026, Asset Utilization Ratio rose 134.22% year-over-year to 0.62; the TTM figure through Jun 2026 stood at 0.62 (up 134.22% YoY), while the FY2025 annual figure was 0.74, up 272.53% from the prior year.
• Asset Utilization Ratio came in at 0.62 for Q2 2026 at Cue Biopharma, up from 0.41 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.62 in Q2 2026 to a low of 0.0 in Q1 2023.
• Average Asset Utilization Ratio over 5 years is 0.18, with a median of 0.17 recorded in 2022.
• Year-over-year, Asset Utilization Ratio sank 96.98% in 2023 and jumped 2333.89% in 2024.
• Over 5 years, Asset Utilization Ratio stood at 0.01 in 2022, then soared by 466.62% to 0.08 in 2023, then jumped by 186.51% to 0.24 in 2024, then jumped by 68.66% to 0.41 in 2025, then jumped by 51.55% to 0.62 in 2026.
• Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.62 in Q2 2026, 0.41 in Q4 2025, and 0.2 in Q3 2025.